CBDY (Target Group) Common Stock : $0.06 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Target Group Common Stock?

Target Group's quarterly common stock stayed the same from Mar. 2024 ($0.06 Mil) to Jun. 2024 ($0.06 Mil) and stayed the same from Jun. 2024 ($0.06 Mil) to Sep. 2024 ($0.06 Mil).

Target Group's annual common stock stayed the same from Dec. 2021 ($0.06 Mil) to Dec. 2022 ($0.06 Mil) and stayed the same from Dec. 2022 ($0.06 Mil) to Dec. 2023 ($0.06 Mil).

Target Group Common Stock Historical Data

The historical data trend for Target Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Target Group Common Stock Chart

Target Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.06

Target Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															0.06	0.06	0.06	0.06	0.06

Target Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Target Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7

Website

https://www.targetgroupinc.ca

Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.

Executives

Barry Alan Katzman	director	36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone	director	564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte	director	18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam	director	42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali	officer: CFO	134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr	director, 10 percent owner, officer: President	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann	director, 10 percent owner, officer: CEO	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust	10 percent owner	52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada)	10 percent owner	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr	other: See Remarks	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy	director, 10 percent owner, officer: president	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: vice president	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212